1/20/26 16:33 | 1/15/26 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 1,120 | 9.83 | 0 | 114 | | 63 | D | | | | | | | | | | | | | | |
1/20/26 16:33 | 1/15/26 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -1,783 | 15.64 | 0 | -114 | -64 | 63 | D | | | | | | | | | | | | | | |
12/29/25 16:15 | 12/23/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Macdonald Kelly | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 30 | 97 | 60 | D | | | | | | | | | | | | | | |
12/29/25 16:12 | 12/23/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Metzinger Joseph Anthony | CA | O | VP,Chief | M.d | 0 | 0.00 | 0 | 13 | | 7 | D | | | | | | | | | | | | | | |
12/29/25 16:09 | 12/23/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.dm | 241 | 3.37 | 0 | 71 | | 63 | D | | | | | | | | | | | | | | |
12/29/25 16:09 | 12/24/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -465 | 15.49 | 0 | -30 | -32 | 63 | D | | | | | | | | | | | | | | |
12/29/25 16:08 | 12/23/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Slebir John L | CA | O | SVP GC | M.d | 0 | 0.00 | 0 | 31 | 79 | 70 | D | | | | | | | | | | | | | | |
12/29/25 16:05 | 12/23/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 100 | 36 | 380 | D | | | | | | | | | | | | | | |
8/25/25 08:50 | 8/22/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Myers Scott Dunseth | CA | D | | P | 41 | 10.82 | 0 | 4 | 12 | 35 | D | | | | | | | | | | | | | | |
8/22/25 20:49 | 8/21/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Deep Track Biotechnology Master Fund, Ltd. | E9 | T | | S.m | -22,352 | 10.82 | 0 | -2,065 | -12 | 15,726 | D | | | | | | | | | | | | | | |
3/26/25 17:04 | 3/24/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 68 | 6.81 | 0 | 10 | | 8 | D | | | | | | | | | | | | | | |
3/26/25 17:04 | 3/24/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -140 | 14.00 | 0 | -10 | -55 | 8 | D | | | | | | | | | | | | | | |
3/20/25 18:15 | 3/18/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S | -190 | 13.58 | 0 | -14 | -63 | 8 | D | | | | | | | | | | | | | | |
3/10/25 21:44 | 3/7/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S | -471 | 14.39 | 0 | -33 | -60 | 22 | D | | | | | | | | | | | | | | |
2/21/25 16:39 | 2/18/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Slebir John L | CA | O | SVP GC | M.d | 0 | 0.00 | 0 | 17 | 85 | 36 | D | | | | | | | | | | | | | | |
2/20/25 19:52 | 2/18/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 0 | 0.00 | 0 | 12 | 18 | 77 | D | | | | | | | | | | | | | | |
2/20/25 19:29 | 2/18/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Macdonald Kelly | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 15 | 113 | 29 | D | | | | | | | | | | | | | | |
2/20/25 19:21 | 2/18/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 55 | 27 | 261 | D | | | | | | | | | | | | | | |
2/20/25 19:16 | 2/18/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 23 | 70 | 55 | D | | | | | | | | | | | | | | |
2/18/25 17:24 | 2/13/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 63 | 35 | 242 | D | | | | | | | | | | | | | | |
2/18/25 17:14 | 2/13/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Slebir John L | CA | O | SVP GC | M.d | 0 | 0.00 | 0 | 14 | 127 | 25 | D | | | | | | | | | | | | | | |
2/18/25 17:13 | 2/13/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 27 | 162 | 43 | D | | | | | | | | | | | | | | |
2/18/25 17:10 | 2/13/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Macdonald Kelly | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 16 | 587 | 19 | D | | | | | | | | | | | | | | |
2/18/25 17:08 | 2/13/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 0 | 0.00 | 0 | 13 | 23 | 70 | D | | | | | | | | | | | | | | |
2/12/25 17:37 | 2/10/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 9 | 47 | 28 | D | | | | | | | | | | | | | | |
2/12/25 17:35 | 2/10/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Slebir John L | CA | O | SVP GC | M.d | 0 | 0.00 | 0 | 5 | 48 | 14 | D | | | | | | | | | | | | | | |
2/12/25 17:01 | 2/10/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 21 | 11 | 211 | D | | | | | | | | | | | | | | |
2/12/25 16:59 | 2/10/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Macdonald Kelly | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 5 | 197 | 8 | D | | | | | | | | | | | | | | |
2/12/25 16:57 | 2/10/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 0 | 0.00 | 0 | 4 | 8 | 61 | D | | | | | | | | | | | | | | |
2/12/25 16:49 | 2/10/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | VP Finan | M.d | 0 | 0.00 | 0 | 7 | | 4 | D | | | | | | | | | | | | | | |
6/3/24 17:37 | 5/31/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Cano Francis | CA | D | | S | -43 | 11.93 | 0 | -4 | -9 | 37 | D | | | | | | | | | | | | | | |
5/28/24 20:18 | 5/24/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Cano Francis | CA | D | | M.d | 44 | 5.90 | 0 | 8 | 23 | 41 | D | | | | | | | | | | | | | | |
3/4/24 17:25 | 3/1/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | M.d | 74 | 10.45 | 0 | 7 | | 0 | D | | | | | | | | | | | | | | |
3/4/24 17:25 | 3/1/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | S.d | -262 | 12.78 | 0 | -21 | -100 | 0 | D | | | | | | | | | | | | | | |
2/20/24 16:42 | 2/16/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | M.d | 0 | 0.00 | 0 | 7 | 99 | 13 | D | | | | | | | | | | | | | | |
2/13/24 20:56 | 2/10/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 9 | 73 | 21 | D | | | | | | | | | | | | | | |
2/13/24 20:46 | 2/10/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 0 | 0.00 | 0 | 4 | 8 | 59 | D | | | | | | | | | | | | | | |
2/13/24 17:25 | 2/10/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 21 | 12 | 201 | D | | | | | | | | | | | | | | |
2/13/24 17:21 | 2/10/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | M.d | 0 | 0.00 | 0 | 7 | 270 | 9 | D | | | | | | | | | | | | | | |
2/13/24 17:16 | 2/10/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Macdonald Kelly | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 5 | | 5 | D | | | | | | | | | | | | | | |
2/7/24 20:41 | 2/3/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.ad | 0 | 0.00 | 0 | 10 | 22 | 56 | D | | | | | | | | | | | | | | |
2/6/24 16:45 | 2/3/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 18 | | 15 | D | | | | | | | | | | | | | | |
2/6/24 16:33 | 2/4/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 30 | 18 | 191 | D | | | | | | | | | | | | | | |
2/6/24 16:32 | 2/3/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 0 | 0.00 | 0 | 10 | 22 | 56 | D | | | | | | | | | | | | | | |
2/6/24 16:31 | 2/3/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | M.d | 0 | 0.00 | 0 | 8 | | 5 | D | | | | | | | | | | | | | | |